BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Diabetes. Mar 15, 2026; 17(3): 115097
Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.115097
Machine learning and deep learning in predicting the risk of diabetic kidney disease: A systematic review and meta-analysis
Qing Chen, Hua-Wei Peng, Chen-Xiao Fu, Kai-Kai Meng, Jun-Bei Zhang
Qing Chen, Kai-Kai Meng, Jun-Bei Zhang, Department of Endocrinology, The Yiwu Central Hospital, Yiwu 322000, Zhejiang Province, China
Hua-Wei Peng, Department of Clinical Laboratory, The Yiwu Maternity and Children Hospital, Yiwu 322000, Zhejiang Province, China
Chen-Xiao Fu, Department of General Practice, Chengxi Community Health Service Center, Yiwu 322000, Zhejiang Province, China
Author contributions: Chen Q and Peng HW contribution to investigated; Chen Q and Fu CX contribution to analyzed the data; Chen Q and Meng KK contribution to wrote the original draft; Peng HW, Fu CX, and Meng KK contribution to collected the data; Zhang JB contribution to reviewed and edited the manuscript and supervised the study; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Corresponding author: Jun-Bei Zhang, Department of Endocrinology, The Yiwu Central Hospital, No. 699 Jiangdong Road, Yiwu 322000, Zhejiang Province, China. e1677716412@126.com
Received: October 9, 2025
Revised: November 18, 2025
Accepted: February 4, 2026
Published online: March 15, 2026
Processing time: 154 Days and 20 Hours
Abstract
BACKGROUND

Machine learning (ML) and deep learning (DL) algorithms have been utilised to predict the risk of diabetic kidney disease (DKD) in individuals with type 2 diabetes mellitus (T2DM). Despite promising results, concerns regarding the clinical applicability and performance of these artificial intelligence models remain.

AIM

To evaluates the performance of ML-based and DL-based models in predicting DKD risk among T2DM patients.

METHODS

A systematic search was conducted across five databases. The risk of bias was assessed using the prediction model risk of bias assessment tool. After data extraction, summary point estimates of the area under the receiver operating characteristic curve (AUC) were aggregated. Heterogeneity was evaluated with the I2 statistic and Cochrane Q test, and subgroup analyses were performed to identify potential sources of heterogeneity.

RESULTS

Twelve eligible studies were included. The pooled AUC for the top-performing artificial intelligence models was 0.858 [95% confidence interval (CI): 0.779-0.912], with a prediction interval of 0.480-0.975. Significant heterogeneity was detected (I2 = 99.7%). Studies employing cross-validation methods demonstrated significantly higher diagnostic accuracy (pooled AUC = 0.88; 95%CI: 0.79-0.94) compared to those using simple holdout validation (pooled AUC = 0.77; 95%CI: 0.59-0.89, P = 0.0231). Predictive factors most frequently used for DKD prediction included age, body mass index, estimated glomerular filtration rate, serum creatinine, urinary albumin, glycated hemoglobin, systolic blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides.

CONCLUSION

ML and DL algorithms exhibit strong performance in predicting DKD in patients with T2DM. However, future research should focus on standardizing model development and validation processes.

Keywords: Diabetic kidney disease; Type 2 diabetes mellitus; Predicting; Deep learning; Machine learning; Artificial intelligence

Core Tip: Machine learning and deep learning algorithms show great performance in predicting diabetic kidney disease (DKD) among type 2 diabetes mellitus patients. Predictors, such as age, body mass index, estimated glomerular filtration rate, serum creatinine, urinary albumin, glycated hemoglobin, systolic blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides, play significant roles in DKD prediction. Models employing cross-validation methods exhibit superior predictive capability for DKD compared to those using holdout validation approaches.